Compliance
This section focuses on health care compliance and regulations – both national and state – including the ACA. It includes changes in health care law, regulation, and court decisions and their impact on health insurance professionals, employers, and individuals.
California’s insurance commissioner, Dave Jones, put executives of insurance giants Aetna Inc. and Humana Inc. in the hot seat Tuesday over their proposal for a merger that could create the nation’s third largest insurer.
The federal government paid bonuses to 231 hospitals with subpar quality because their patients tend to be less expensive for Medicare, new research shows.
Covered California’s Obamacare exchange has helped consumers get a better deal on health insurance in part because of its negotiating power — power that other Affordable Care Act marketplaces don’t have — according to a new analysis published Monday.
When the health insurance premiums got to the point that they were higher than her mortgage, Renee Powell started to become cynical.
Rep. Ami Bera and 15 members of the California delegation are pushing the heads of California Health and Human Services and the California Health Benefit Exchange in a letter to address a computer glitch that is terminating Covered California Care for pregnant women.
Why does a knee replacement cost $29,000 in Kansas but $40,000 in next-door Colorado?
Federal regulators proposed a rule Wednesday that will adjust hundreds of thousands of physicians'Medicare payments to reward or penalize them based on how healthy they keep their patients.
Over the course of an hour on Wednesday, Don Goldmannheld his audience spellbound, recounting tales about the mythical Trojan horse, a smooth talker who sold “premium” wine at $2 per bottle for Trader Joe’s, and the calling out of random numbers in a penitentiary that invoked raucous laughter among its prisoners.
U.S. House of Representatives Speaker Paul Ryan called on Wednesday for an end to Obamacare's financial protections for people with serious medical conditions, saying these consumers should be placed in state high-risk pools.
From the campaign trail to the halls of Congress, drug makers have spent much of the last year enduring withering criticism over the rising cost of drugs. It doesn’t seem to be working.